The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Mar. 27, 2012
Filed:
Feb. 07, 2005
Kazuo Hattori, Kanagawa, JP;
Satoshi Niizuma, Kanagawa, JP;
Takehiro Okada, Kanagawa, JP;
Hiroyuki Eda, Kanagawa, JP;
Kenji Tatsuno, Kanagawa, JP;
Miyuki Yoshida, Kanagawa, JP;
Kazuo Hattori, Kanagawa, JP;
Satoshi Niizuma, Kanagawa, JP;
Takehiro Okada, Kanagawa, JP;
Hiroyuki Eda, Kanagawa, JP;
Kenji Tatsuno, Kanagawa, JP;
Miyuki Yoshida, Kanagawa, JP;
Chugai Seiyaku Kabushiki Kaisha, Tokyo, JP;
Abstract
The present invention provides: a compound represented by the following formula (I): [wherein Yand Yrepresent a hydrogen atom or a halogen atom; either one of Yand Yrepresents —NRR, and the other represents a hydrogen atom or a halogen atom; X represents an aryl group or a heteroaryl group that may be substituted; Rrepresents a hydrogen atom, or a Calkyl group that may be substituted; and Rrepresents a Calkyl group that is substituted with one or more substituents, —COOR, —COR, —COSR, —CONRR, —NRR, or —C═NRR; or Rand R, together with a nitrogen atom to which they are bonded, may form a 4- to 10-membered hetero ring containing at least one nitrogen atom (wherein the hetero ring may be substituted with one or more substituents selected from Group C)], a prodrug thereof, or a pharmaceutically acceptable salt thereof; and a pharmaceutical, a pharmaceutical composition, or the like, which comprises the compound.